Does empagliflozin improve atrial remodeling and mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats?
Empagliflozin may help prevent T2DM-related atrial fibrillation by ameliorating atrial structural and electrical remodeling and improving mitochondrial function.
Empagliflozin can ameliorate atrial structural and electrical remodeling as well as improve mitochondrial function and mitochondrial biogenesis in T2DM, hence may be potentially used in the prevention of T2DM-related atrial fibrillation.
Shao et al. (Thu,) studied this question.